Silexion Therapeutics prices USD 2.5 million public offering at USD 0.65 per share with warrants
Reuters2026/08/12 00:01- Silexion Therapeutics priced a USD 2.5 million public offering of 3,846,161 ordinary shares or equivalents with Series E warrants.
- Combined offering price set at USD 0.65 per share or equivalent, including accompanying warrants.
- Series E warrants carry a USD 0.65 exercise price, are exercisable immediately, expire five years from issuance.
- Closing expected on Aug. 13, 2026, subject to customary closing conditions.
- Net proceeds earmarked to advance the SIL204 clinical trial, fund general corporate purposes.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Preferred shares of South Korean companies are trading at a record 45% discount in ten years; Samsung's 110 trillion won buyback plan may help eliminate the "Korea discount"
Samsung Electronics' highly anticipated stock buyback plan is raising investor expectations that the South Korean giant will purchase non-voting preferred shares, narrowing their deep discount and setting a precedent for other companies.
A standout performer, privacy coins become the biggest winners in the crypto market this year
Crypto Zhong Liang: 9.8 BTC/ETH Market Perspective
PTPP nears completion of Rp 1.46 trillion Kataraja toll road section at 94.9%
Crypto prices
More
